Indicated for: glaucoma; ocular hypertension
Substance: travoprost + timolol (glaucoma agent + beta blocker)
ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)
Travoprost+timolol is a combination medication used in the treatment of open-angle glaucoma and ocular hypertension. Travoprost is a prostaglandin F2-alpha analog that reduces intraocular pressure by increasing the outflow of aqueous humor, while timolol is a beta-blocker that decreases aqueous humor production.
This combination is administered as eye drops, usually once daily in the evening. It is indicated for patients who do not respond adequately to monotherapy or require additional intraocular pressure reduction.
Common side effects include ocular irritation, conjunctival hyperemia, dry eyes, and a burning sensation. In rare cases, systemic adverse reactions such as bradycardia, hypotension, or respiratory difficulties may occur. It is important for patients to follow their doctor's instructions and avoid contact of the dropper tip with the eye or other surfaces.
Travoprost+timolol is an effective therapeutic option for managing elevated intraocular pressure, helping to prevent optic nerve damage and vision loss.